Gebelikte Radyasyon Maruziyeti

La Vignera S, Condorelli RA, Vicari E, et al. Effects of the exposure to mobile phones on male reproduction: a review of the literature. J Androl. 2012;33(3):350-356.
Çoruh, D. The Effect Of MobIle Phone On The MotIlIty And Dna ıntegrIty Of Human Sperm. Selcuk Med J. 2014;.30(4):165-168.
Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA General Safety Requirements 2014;3:10-11.
Daşdağ S. İyonlaştırıcı radyasyonlar ve kanser. Dicle Med J. 2010;37(2):177–185.
Yeyin N. Radyasyonun biyolojik etkileri. Nucl Med Semin. 2015;3:139–143.
Nakagawa K, Aoki Y, Kusama T et al. Radiotherapy during pregnancy: Effect on fetus and neonates. Clin Ther. 1997; 19(4): 770- 776.
Stabin MG. Radiation dose and risks to fetus from nuclear medicine procedures. Phys Med. 2017;43:190-198.
ICRP. The 2007 Recommendations of International Commission on Radiological Protection. ICRP Publication 103. Amsterdam, Elseveier. 2007; 37: 2-4.
NCRP (National Concil on Radiation Protection and Measurements) Exposure of the U.S. population from diagnostic medical radiation. NCRP Publication 100. 1989 Report 54.
Baciak JE, Kearfott KJ. Review of Fetal Radiation Dose Protection and Dosimetry Issues for Medical Procedures. RADIATION PROTECTION MANAGEMENT, 2000;17(1):39-42.
Osei EK, Faulkner K. Radiation risk from exposure to diagnostic x-ray during pregnancy. Radiography. 200;6:131- 144.
Osei EK, Faulkner K. Fetal doses from radiologycal examinations. Br J Radiol. 1999:72;773- 780.
Sharp C, Shrimpton JA, Bury RF. Diagnostic medical exposures advice on exposure to ionising radiation during pregnancy. Joint guidence from National Radiological Protection Board College of Radiographers and Royal College of Radiologists. NRPB. Chilton, 1998.
Fetal radiation dose extimates. www. safety. duke. edu. 08/ 07/ 2009.
Parry RA, Gdace S, Archor BR. The AAPM/RSNA Physics Tutorial for residents typical patient radiation in diagnostic radiology. Imaging&Therapeutic Technology. 1999; 12-1302.
Patel SJ, Reede DL, Katz DS et al. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. Radiographics. 2007;27(6):1705-1722.
Webb JA, Thomsen H, Morcos S. Members of Contrast Media Safety Committee of European Society of Urogenital Radiology. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234-1240
Bourjeily G, Chalhoub M, Phornphutkul C et al. Neonatal thyroid function: effect of a single exposure to iodinated contrast medium in utero. Radiology. 2010;256:744-750
Widmark JM. Imaging-related medications: a class overview. Proc (Bayl Univ Med Cent). 2007; 20:408–417
Watson EE. Radiation absorbed dose to the human fetal thyroid. In: Fifth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN: Oak Ridge Associated Universities. 1992;179–187.
Russell JR, Stabin MG, Sparks RB et al. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997;73(5):756–769.
Bilge H. Pregnancy and radiation. J Turk Soc Obstet Gynecol. 2010;7(1):37-42.
Mole RH. Radiation effects on prenatal development and their radiological significance. Br J Radiol. 1979;52:89-101.
Brent RL. The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: counseling the pregnant and nonpregnant patient about these risks. Semin Oncol. 1989;16: 347-368.
Hall EJ. Scientific view of low-level radiation risks. Radiographics 1991;11:509-518.
National Research Council. Other somatic and fetal effect. In: Health effect of exposure to low level of ionizing radiation: BEIR V. Washington, DC. National Academy Pres. 1990; 352-370.
Russell J, Stabin M, Sparks R. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys. 1997;73(5):747–755.
International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP. 2000;30(1):1-43.
Stewart A, Webb J, Hewitt D. A survey of childhood malignancies. BMJ. 1958:30;1495- 1505.
MacMahon B. Prenatal X-ray exposure and childhood cancer. J. Natl Cance Inst. 1982:28;1173- 1191.
Preston DL, Cullings H, Suyama A et al. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children. J Natl Cancer Inst. 2008;100:428–436.
Mountford PJ, Steele HR. Fetal dose extimates and the ICRP abdominal dose limit for occupotional exposure of pregnant staff to technetium-99m and Iyodine -131 patients. Eur J Nucl Med Mol Imaging. 2004: 22(10); 1173- 1179.